Patent · US Expired

Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same

US6670350B1 · kind B1 · utility

3Cited by

1References

4Claims

0Family size

Assignee

Jenapharm GmbH & Co. KG · DE

Inventors

Michael Oettel · Jena, DE
Claudia Moore · Jena, DE
Adolf Eduard Schindler · Essen, DE
Bernd Christensen · Liederbach, DE

Key dates

Filing date	Jan 14, 2002
Grant date	Dec 30, 2003
Priority date	—
Expiry date	Jan 14, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of administering dienogest to a women in high dosages for reducing the body of the breast is described. The dosage should be at least ten times the effective dosage for inhibiting ovulation in the women. A pharmaceutical composition for use in the method is also described. Furthermore, retrogression of mastopathic changes in the body of the breast can be brought about. Dienogest is also outstandingly suitable for the prophylaxis of mastopathies. In high dosages, dienogest prevents the formation of mastopathic changes in the body of the breast.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.